-
COVID-19 Likely to Delay Rare Disease and Gene Therapy Trials
Pharma executives at the World Orphan Drug Congress noted delays due to pandemic in some trials for gene therapies and rare diseases, but remain optimistic. Click here to read more.
Do you feel optimistic or are you worried about the impact of COVID-19 on LEMS research and drug trials?
Sorry, there were no replies found.
Log in to reply.